The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Oral Session

Oral Session 2-13D DIC

Sat. Oct 13, 2018 4:00 PM - 5:00 PM No.13 (Osaka International Convention Center, 11F 1101-2)

Chair: Eriko Morishita (Department of Laboratory Sciences, Kanazawa University, Japan)

[OS2-13D-4] Reduced dose rhTM is not recommended for treatment of DIC with hematologic malignancies

Yosuke Okada, Ken Sato, Masahiro Teramoto, Noriaki Tachi, Toshikuni Kawamura, Shoichiro Kato, Takaaki Maekawa, Shinichi Kobayashi, Fumihiko Kimura (Division of Hematology, National Defense Medical College Hospital, Saitama, Japan)

Abstract password authentication.
Password is written on a program and abstract book.

Password